CTV / Innovid Corp. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

Innovid Corp.
US ˙ NYSE ˙ US4576791085
HINDI NA ACTIVE ANG SIMBONG ITO

Mga Batayang Estadistika
CIK 1835378
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Innovid Corp.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
February 24, 2025 15-12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-40048 INNOVID CORP. (Exact name of registrant as specified in its charte

February 21, 2025 POS AM

As filed with the Securities and Exchange Commission on February 21, 2025

As filed with the Securities and Exchange Commission on February 21, 2025 Registration No.

February 14, 2025 RW

February 14, 2025

February 14, 2025 Via Edgar United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.

February 14, 2025 S-8 POS

As filed with the U.S. Securities and Exchange Commission on February 14, 2025

As filed with the U.S. Securities and Exchange Commission on February 14, 2025 Registration No. 333-262537 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-262537 UNDER THE SECURITIES ACT OF 1933 INNOVID CORP. (Exact name of registrant as specified in its charter) Delaware 87-3769599 (State or other ju

February 13, 2025 EX-99.25

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on February 24, 2025, pursuant to the provisions of Rule 12d2-2 (a).

February 13, 2025 EX-3.1

AMENDED AND RESTATED CERTIFICATE OF INCORPORATION INNOVID CORP.

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF INNOVID CORP. Innovid Corp., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), hereby certifies as follows: The name of the Corporation is Innovid Corp. The date of filing of the original Certificate of Incorporation of the Corporation with the Secretary of State of the State of Delawar

February 13, 2025 EX-3.2

AMENDED AND RESTATED BY-LAWS INNOVID CORP. (the “Corporation”) ARTICLE I

Exhibit 3.2 Final Form AMENDED AND RESTATED BY-LAWS OF INNOVID CORP. (the “Corporation”) ARTICLE I STOCKHOLDERS Section 1. Annual Meeting. The annual meeting of the stockholders of the Corporation (the “Stockholders”) shall be held either within or without the State of Delaware, at such place as the board of directors of the Corporation (the “Board of Directors”) may designate in the call or in a

February 13, 2025 8-K

Regulation FD Disclosure, Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2025 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

February 13, 2025 EX-99.1

Mediaocean Completes Acquisition of Innovid – Creating the Premier Global Independent, Omnichannel Ad Tech Platform

Exhibit 99.1 Mediaocean Completes Acquisition of Innovid – Creating the Premier Global Independent, Omnichannel Ad Tech Platform Innovid & Flashtalking Unite Under Mediaocean to Give Advertisers More Control, Choice, and Transparency NEW YORK – Feb. 13, 2025 – Mediaocean today announced the successful completion of its acquisition of Innovid, bringing together Innovid and Flashtalking to form an i

February 13, 2025 EX-99.2

Innovid Corp. 116 E 16th Street, 6th Floor New York, NY 10003

Exhibit 99.2 Innovid Corp. 116 E 16th Street, 6th Floor New York, NY 10003 February 13, 2025 Continental Stock Transfer & Trust Company 1 State Street, 30th Floor New York, NY 10004 Attention: Compliance Department Re: Notice of Merger of the Company (Warrant No. CUSIP-457679116) Dear Warrant Holder: Reference is made to (i) that certain Warrant Agreement, dated as of February 10, 2021 (the “Warra

February 11, 2025 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2025 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

February 3, 2025 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 3, 2025 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com

February 3, 2025 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14A (Rule 14a-101) Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to Rule 14a-12 Innovid Corp.

January 10, 2025 DEFM14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box:  ☐ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ D

December 23, 2024 PREM14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant  ☐ Check the appropriate box: ☒ Preliminary Proxy Statement  ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))  ☐ D

December 23, 2024 EX-FILING FEES

CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) Innovid Corp. (Exact Name of Registrant as Specified in its Charter) Table 1: Transaction Valuation

Exhibit 107 CALCULATION OF FILING FEE TABLES Schedule 14A (Form Type) Innovid Corp.

November 21, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 21, 2024 Innovid Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 21, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

November 21, 2024 EX-10.2

CONTRIBUTION AND EXCHANGE AGREEMENT

Exhibit 10.2 Execution Version CONTRIBUTION AND EXCHANGE AGREEMENT IN MAKING AN INVESTMENT DECISION, ROLLOVER STOCKHOLDER MUST RELY ON HIS, HER OR ITS OWN EXAMINATION OF TOPCO (AS DEFINED BELOW) AND ITS SUBSIDIARIES AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THE PARTNERSHIP UNITS TO BE ACQUIRED HEREUNDER HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE OR NON-U.S. SEC

November 21, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive

November 21, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive

November 21, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

DEFA14A 1 ea022209202-defa14ainnovid.htm SOLICITING MATERIAL UNDER RULE 14A-12 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential,

November 21, 2024 DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive

November 21, 2024 EX-10.1

SUPPORT AGREEMENT

Exhibit 10.1 Execution Version SUPPORT AGREEMENT SUPPORT AGREEMENT, dated as of November 21, 2024 (this “Support Agreement”), among Mediaocean LLC, a Delaware limited liability company (“Parent”), and the undersigned stockholder(s) of Innovid Corp., a Delaware corporation (the “Company”), listed on the signature pages hereto (each, a “Stockholder” and, collectively, the “Stockholders”). W I T N E

November 21, 2024 EX-99.1

Mediaocean to Acquire Innovid (NYSE:CTV)

Exhibit 99.1 Mediaocean to Acquire Innovid (NYSE:CTV) Innovid will Merge with Flashtalking by Mediaocean to Create a Premier Independent, Omnichannel Ad Tech Platform NEW YORK, Nov. 21, 2024 – Mediaocean, a foundational partner for omnichannel advertising, and Innovid (NYSE:CTV), an independent software platform for the creation, delivery, measurement, and optimization of advertising, today announ

November 21, 2024 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 21,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 21, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation

November 21, 2024 EX-99.1

Mediaocean to Acquire Innovid (NYSE:CTV) Innovid will Merge with Flashtalking by Mediaocean to Create a Premier Independent, Omnichannel Ad Tech Platform

Exhibit 99.1 Mediaocean to Acquire Innovid (NYSE:CTV) Innovid will Merge with Flashtalking by Mediaocean to Create a Premier Independent, Omnichannel Ad Tech Platform NEW YORK, Nov. 21, 2024 – Mediaocean, a foundational partner for omnichannel advertising, and Innovid (NYSE:CTV), an independent software platform for the creation, delivery, measurement, and optimization of advertising, today announ

November 21, 2024 EX-99.1

Mediaocean to Acquire Innovid (NYSE:CTV) Innovid will Merge with Flashtalking by Mediaocean to Create a Premier Independent, Omnichannel Ad Tech Platform

Exhibit 99.1 Mediaocean to Acquire Innovid (NYSE:CTV) Innovid will Merge with Flashtalking by Mediaocean to Create a Premier Independent, Omnichannel Ad Tech Platform NEW YORK, Nov. 21, 2024 – Mediaocean, a foundational partner for omnichannel advertising, and Innovid (NYSE:CTV), an independent software platform for the creation, delivery, measurement, and optimization of advertising, today announ

November 21, 2024 EX-2.1

AGREEMENT AND PLAN OF MERGER by and among MEDIAOCEAN LLC, IGNITE MERGER SUB, INC. INNOVID CORP. Dated as of November 21, 2024 TABLE OF CONTENTS

Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among MEDIAOCEAN LLC, IGNITE MERGER SUB, INC. and INNOVID CORP. Dated as of November 21, 2024 TABLE OF CONTENTS Page Article I DEFINITIONS & INTERPRETATIONS 2 1.1 Certain Definitions 2 1.2 Additional Definitions 16 1.3 Certain Interpretations 18 Article II THE MERGER 21 2.1 The Merger 21 2.2 The Effective Time 21 2.3 The Closing 21

November 21, 2024 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 21, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

November 14, 2024 SC 13G/A

CTV / Innovid Corp. / Phoenix Holdings Ltd. - SC 13G/A Passive Investment

SC 13G/A 1 zk2432315.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* Innovid Corp (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 457679108 (CUSIP Number) September 30, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropr

November 12, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048

November 12, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 12, 2024 Innovid Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 12, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

November 12, 2024 EX-99.1

Innovid Reports Q3 2024 Financial Results

Exhibit 99.1 Innovid Reports Q3 2024 Financial Results ●Q3 2024 revenue increased 6% year-over-year to $38.3 million ●Q3 2024 net income improved year-over-year to $4.7 million and Adjusted EBITDA* increased 29% year-over-year to $8.4 million ●Adjusted EBITDA margin* increased to 22%, the ninth consecutive quarter of expansion ●Company announces board approval to implement stock repurchase program

November 12, 2024 EX-10.1

aration Agreement between Innovi

Exhibit 10.1 SEPARATION AGREEMENT, WAIVER, AND GENERAL RELEASE This SEPARATION AGREEMENT, WAIVER, AND GENERAL RELEASE (“Agreement”) is made by and between Innovid, LLC, with offices at 30 Irving Place, 12th Floor, New York, NY 10003 (“Innovid” or the “Company”) and Dave Helmreich (hereinafter “Executive”) (each a “party” and collectively, the “parties”). Executive’s employment with the Company end

September 18, 2024 EX-10.01

Mutual Separation Agreement between Innovid Corp. and David Helmreich dated September 15, 2024.

Exhibit 10.1 1 SEPARATION AGREEMENT, WAIVER, AND GENERAL RELEASE This SEPARATION AGREEMENT, WAIVER, AND GENERAL RELEASE (“Agreement”) is made by and between Innovid, LLC, with offices at 30 Irving Place, 12th Floor, New York, NY 10003 (“Innovid” or the “Company”) and Dave Helmreich (hereinafter “Executive”) (each a “party” and collectively, the “parties”). Executive’s employment with the Company e

September 18, 2024 8-K/A

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or o

September 3, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Comm

August 6, 2024 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2024 Innovid Corp. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 6, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi

August 6, 2024 EX-10.1

Second Loan Modification Agreement, by and among Silicon Valley Bank, a Division of First-Citizens Bank & Trust Company, and each of the Borrowers set forth therein, dated June 26, 2024

EXHIBIT 10.1 SECOND LOAN MODIFICATION AGREEMENT This Second Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of June 26, 2024, by and among (a) SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY (“Bank”) and (b) (i) INNOVID LLC, a Delaware limited liability company with its principal place of business located at 30 Irving Place 12th Floor New

August 6, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 Inno

August 6, 2024 EX-99.1

Innovid Reports Q2 2024 Financial Results

Exhibit 99.1 Innovid Reports Q2 2024 Financial Results ●Q2 2024 revenue increased 10% year-over-year to $38.0 million ●Q2 2024 net loss improved year-over-year to $10.5 million and Adjusted EBITDA* increased 29% year-over-year to $5.9 million ●Adjusted EBITDA margin increased to 15.5%, the eighth consecutive quarter of expansion ●CTV impression volume from ad serving and personalization increased

August 1, 2024 SC 13G

CTV / Innovid Corp. / Phoenix Holdings Ltd. - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* Innovid Corp (Name of Issuer) Common stock, par value $0.0001 per share (Title of Class of Securities) 457679108 (CUSIP Number) July 29, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant

August 1, 2024 EX-99

Notice of resolution of the Board of Directors of the Phoenix Holdings Ltd., dated as of December 12, 2019.

Exhibit 1 [Unofficial Translation] December 12, 2019 Powers of Signature in The Phoenix Holdings Ltd.

June 25, 2024 SC 13G/A

CTV / Innovid Corp. / ION Crossover Partners Ltd - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Innovid Corp (Name of Issuer) Common Stock (Title of Class of Securities) 457679 10 8 (CUSIP Number) Mr. Anthony Reich, 13th Floor, Building E, 89 Medinat Hayehudim Street, Herzliya, Israel. +972-9-9703620 (Name, Address and Telephone Number of Person

June 11, 2024 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 10, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commis

May 28, 2024 SC 13G

CTV / Innovid Corp. / ION Crossover Partners Ltd - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Innovid Corp (Name of Issuer) Common Stock (Title of Class of Securities) 457679 10 8 (CUSIP Number) Mr. Anthony Reich, 13th Floor, Building E, 89 Medinat Hayehudim Street, Herzliya, Israel. +972-9-9703620 (Name, Address and Telephone Number of Person Aut

May 24, 2024 SC 13G/A

CTV / Innovid Corp. / SEQUOIA CAPITAL ISRAEL IV, L.P. - SC 13G/A Passive Investment

SC 13G/A 1 d675581dsc13ga.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. 1)* Innovid Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (

May 7, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 7, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commissi

May 7, 2024 EX-99.1

Innovid Reports Q1 2024 Financial Results

Exhibit 99.1 Innovid Reports Q1 2024 Financial Results •Company exceeds both revenue and Adjusted EBITDA guidance for Q1 •Q1 revenue grew to $36.7 million, up 21% year-over-year •Q1 net loss improved year-over-year to $6.2 million and Adjusted EBITDA* improved to $4.4 million, representing a 12% Adjusted EBITDA margin* •Company raises full-year 2024 guidance NEW YORK, May 7, 2024 - Innovid Corp. (

May 7, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 Inn

April 30, 2024 DEFA14A

Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.co

Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance.

April 29, 2024 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

April 1, 2024 SC 13G/A

CTV / Innovid Corp. / Vintage Fund 5 Ltd. - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment

SC 13G/A 1 ea0203062-13ga1vintag5innov.htm AMENDMENT NO. 1 TO SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Innovid Corp. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title

March 12, 2024 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 12, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi

February 29, 2024 EX-97.1

olicy for Recovery of Erroneously Award

INNOVID CORP. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION Innovid Corp. (the “Company”) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the “Policy”), effective as of November 21, 2023 (the “Effective Date”). Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 11. 1. Persons Subject to Policy This Policy shall apply to

February 29, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2023 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 Innovid Cor

February 29, 2024 EX-10.18

Employment Agreement between the Company and

February 29, 2024 EX-10.17

Employment Agreement between the Company and Dave Helmreich, dated December 13, 2022

11/2/2022 To: David Helmreich Offer of Employment Dear David Innovid, LLC. (“Innovid” or the "Company") is pleased to extend you this opportunity to work for the Company as Chief Commercial Officer. This letter sets forth information about the position that you are being offered at this time. Should you determine that you are interested in this position and would like to commence employment with t

February 29, 2024 EX-10.19

Employment Agreement between the Company and

tNN0*L'S runc26,2012 T.i r.nr. Andr4ca ksFin inioLdrnnovi4.oo 534 gr.adway,suitc 1205, NY, Ny 1001? Te| 21t 965.7S55 r&r,in.ov d.os Rei otl€i., Em.lovn.nt 0e* Mt. Andreev-(aspri, hrovid li.. {the Conpany l 15 plci5.n 1o off€r yo! the sosition oi cont.olle., this letter embo.i.,::t. (erm5 of.!r alae. ot.mploym.nr lo you. As, a.ntroler Vou will repo* lo Mr. l:m!s Wenbc.s, ,. r!.h othet perJln rs rh!

February 27, 2024 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 27, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

February 27, 2024 EX-99.1

Innovid Reports Q4 and Fiscal Year 2023 Financial Results

Innovid Reports Q4 and Fiscal Year 2023 Financial Results •Company exceeds both revenue and Adjusted EBITDA guidance for Q4 and full year 2023 •Q4 revenue grew to $38.

February 5, 2024 EX-3.1

Bylaws of Innovid Corp.

Amended and Restated Bylaws of Innovid Corp. (a Delaware corporation) as of February 1, 2024 TABLE OF CONTENTS Page Article I - Corporate Offices 3 1.1 Registered Office 3 1.2 Other Offices 3 Article II - Meetings of Stockholders 3 2.1 Place of Meetings 3 2.2 Annual Meeting 3 2.3 Special Meeting 3 2.4 Notice of Business to be Brought Before a Meeting 4 2.5 Notice of Nominations for Election to the

February 5, 2024 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 1, 2024 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com

November 30, 2023 EX-99.1

INVESTOR DAY November 2023 DISCLAIMERS Forward-Looking Statements This presentation includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1996. The Company's actual

INVESTOR DAY November 2023 DISCLAIMERS Forward-Looking Statements This presentation includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1996.

November 30, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 30, 2023 Innovid Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 30, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

November 8, 2023 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 8, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com

November 8, 2023 EX-32.02

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as ado

November 8, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

November 8, 2023 EX-31.02

Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).

Exhibit 31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Anthony Callini, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which

November 8, 2023 EX-32.01

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. Section 1350, as ado

November 8, 2023 EX-31.01

Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a).

Exhibit 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zvika Netter, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which suc

November 8, 2023 EX-99.1

Innovid Reports Q3 2023 Financial Results

Innovid Reports Q3 2023 Financial Results •Q3 revenue increased to $36.2 million, up 5% year-over-year •CTV revenue from Ad Serving and Personalization, up 9% year-over-year •Company raises full year 2023 guidance NEW YORK, November 8, 2023 /PRNewswire/ - Innovid Corp. (NYSE:CTV) (the "Company"), an independent advertising platform for delivery, personalization, and measurement of converged TV acr

October 16, 2023 EX-10.1

Employment Agreement between the Company and Anthony Callini, dated October 16, 2023

EXHIBIT 10.1 10/13/2023 To: Anthony Callini Offer of Employment Dear Anthony Innovid, LLC. (“Innovid” or the "Company") is pleased to extend to you this conditional offer of employment with the Company as Chief Financial Officer (CFO). This letter sets forth information about the position that you are being offered at this time. Should you determine that you are interested in this position and wou

October 16, 2023 EX-10.2

Transition Agreement and Mutual Separation Agreement between the Company and Tanya Andreev-Kaspin, dated October 16, 202

TRANSITION AGREEMENT, WAIVER, AND GENERAL RELEASE This TRANSITION AGREEMENT, WAIVER, AND GENERAL RELEASE (“Agreement”) is made by and between Innovid, LLC, with offices at 30 Irving Place, 12th Floor, New York, NY 10003 (“Innovid” or the “Company”) and Tanya Andreev-Kaspin (hereinafter “Employee”) (each a “party” and collectively, the “parties”).

October 16, 2023 EX-99.1

Innovid Appoints New CFO and Announces Preliminary Unaudited Q3 2023 Revenue Exceeding Guidance •Preliminary Q3 Revenue of $36M, Above the High End of Guidance •Anthony Callini Named New Chief Financial Officer •Innovid to Release Third Quarter 2023

Innovid Appoints New CFO and Announces Preliminary Unaudited Q3 2023 Revenue Exceeding Guidance •Preliminary Q3 Revenue of $36M, Above the High End of Guidance •Anthony Callini Named New Chief Financial Officer •Innovid to Release Third Quarter 2023 Results on Wednesday, November 8 NEW YORK, Oct.

October 16, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 16, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com

September 14, 2023 POS AM

As filed with the U.S. Securities and Exchange Commission on September 14, 2023

As filed with the U.S. Securities and Exchange Commission on September 14, 2023 Registration No. 333-264324 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other jurisdictio

September 12, 2023 S-1/A

As filed with the U.S. Securities and Exchange Commission on September 12, 2023

As filed with the U.S. Securities and Exchange Commission on September 12, 2023 Registration No. 333-264324 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 ON FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other jurisdictio

August 8, 2023 EX-10.1

Amended and Restated Non-Employee Director Compensation Program

Innovid Corp. Amended and Restated Non-Employee Director Compensation Program (EFFECTIVE JUNE 6, 2023) Non-employee members of the board of directors (the “Board”) of Innovid, Corp. (the “Company”) shall receive cash and equity compensation as set forth in this Amended and Restated Non-Employee Director Compensation Program (this “Program”). The cash and equity compensation described in this Progr

August 8, 2023 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi

August 8, 2023 EX-99.1

Innovid Reports Q2 2023 Financial Results

Innovid Reports Q2 2023 Financial Results •Q2 revenue increased to $34.5 million, up 4% year-over-year •Q2 measurement revenue contributed $7.8 million, up 10% year-over-year, representing 23% of total Q2 revenue •Innovid raises full year 2023 revenue and Adjusted EBITDA* guidance NEW YORK, August 8, 2023 /PRNewswire/ - Innovid Corp. (NYSE:CTV) (the "Company"), an independent advertising platform

August 8, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

August 8, 2023 EX-10.3

First Loan Modification Agreement, by and among Silicon Valley Bank, A Division of First-Citizens Bank & Trust Company, and each of the Borrowers set forth therein, dated August 2, 2023

FIRST LOAN MODIFICATION AGREEMENT This First Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of August 2, 2023, by and among (a) SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY (SUCCESSOR BY PURCHASE TO THE FEDERAL DEPOSIT INSURANCE CORPORATION AS RECEIVER FOR SILICON VALLEY BRIDGE BANK, N.

July 6, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 2, 2023 Innovid Corp. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 2, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss

July 6, 2023 EX-10.1

Employment Agreement between the Company and Zvika Netter, dated July 2, 2023

Certain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) the type that the Registrant treats as private or confidential.

July 5, 2023 EX-99.1

Innovid Regains Compliance with NYSE Continued Listing Standards

Innovid Regains Compliance with NYSE Continued Listing Standards NEW YORK, July 5, 2023 - Innovid Corp.

July 5, 2023 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 3, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss

June 8, 2023 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 7, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss

May 19, 2023 POS AM

As filed with the U.S. Securities and Exchange Commission on May 19, 2023

As filed with the U.S. Securities and Exchange Commission on May 19, 2023 Registration No. 333-261784 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 ON FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other juris

May 19, 2023 EX-99.1

Innovid Receives NYSE Continued Listing Standards Notice

Innovid Receives NYSE Continued Listing Standards Notice NEW YORK, May 19, 2023 – Innovid Corp.

May 19, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 19, 2023 Innovid Corp. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 19, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss

May 17, 2023 SC 13G

CTV / Innovid Corp / ION Holdings 2, LP - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 INNOVID CORP. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title of Class of Securities) 457679108 (CUSIP Number) May 16, 2023 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this Sche

May 17, 2023 EX-99.1

JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)

EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements.

May 9, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 9, 2023 Innovid Corp. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 9, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commissi

May 9, 2023 EX-99.1

Innovid Reports Q1 2023 Financial Results

Innovid Reports Q1 2023 Financial Results •Reports Q1 revenue increased to $30.5 million, up 18% year-over-year •Connected TV (CTV) accounted for 54% of video impressions in Q1 2023, vs. 49% in Q1 2022 NEW YORK, May 9, 2023 - Innovid Corp. (NYSE:CTV) (the "Company"), an independent advertising platform for delivery, personalization, and measurement of converged TV across linear, connected TV (CTV)

May 9, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

May 9, 2023 424B3

INNOVID CORP.

424B3 1 a424b3resale.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 8 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capita

May 9, 2023 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 7 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem

April 26, 2023 DEFA14A

DEFA14A

April 26, 2023 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

April 19, 2023 EX-99.1

Experian Executive Joins Innovid Board of Directors

Experian Executive Joins Innovid Board of Directors NEW YORK, April 19th, 2023 /PRNewswire/ – Innovid Corp.

April 19, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 19, 2023 Innovid Corp. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 19, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi

April 17, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 17, 2023 Innovid Corp. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 17, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commi

April 17, 2023 EX-99.1

Innovid Announces Preliminary Unaudited First Quarter 2023 Revenue and Earnings Conference Call Date

Innovid Announces Preliminary Unaudited First Quarter 2023 Revenue and Earnings Conference Call Date NEW YORK - April 17, 2023 - Innovid Corp.

April 4, 2023 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 202

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or

April 3, 2023 SC 13G

CTV / Innovid Corp / Vintage Fund 5 Ltd. - SCHEDULE 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title of Class of Securities) 457679 108 (CUSIP Number) March 23, 2023 (Date of Ev

March 29, 2023 SC 13D/A

CTV / Innovid Corp / GENESIS PARTNERS III LP - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Innovid Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 457679 108 (CUSIP Number) c/o Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 (212) 966-7555 (Name, Address and Telephone Number of Person Authorized to Rece

March 3, 2023 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 7 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe

March 3, 2023 EX-10.18

Innovid Corp. Form of Restricted Stock Unit Agreement

INNOVID CORP. 2021 OMNIBUS INCENTIVE PLAN RESTRICTED STOCK UNIT GRANT NOTICE Capitalized terms not specifically defined in this Restricted Stock Unit Grant Notice (the “Grant Notice”) have the meanings given to them in the 2021 Omnibus Incentive Plan (as amended from time to time, the “Plan”) of Innovid Corp. (the “Company”). The Company has granted to the participant listed below (“Participant”)

March 3, 2023 EX-10.20

cutive Change in Control Severance Plan

Innovid, Inc. Executive Change in Control Severance Plan ARTICLE I. Establishment, Term, and Purpose 1.1Establishment of the Plan. Innovid, Inc. (the “Company”) hereby establishes a severance plan for key executives, to be known as the Innovid, Inc. Executive Change in Control Severance Plan (the “Plan”). 1.2Plan Participants. The Plan provides Severance Benefits (as described below) to certain em

March 3, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K x Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2022 ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-40048 Innovid Cor

March 3, 2023 EX-10.19

Executive Severance Plan

Innovid, Inc. Executive Severance Plan ARTICLE I. Establishment, Term, and Purpose 1.1Establishment of the Plan. Innovid, Inc. (the “Company”) hereby establishes a severance plan for key executives, to be known as the Innovid, Inc. Executive Severance Plan (the “Plan”). 1.2Plan Participants. The Plan provides Severance Benefits (as described below) to certain employees of the Company, its Subsidia

March 3, 2023 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 6 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem

March 3, 2023 EX-10.17

Innovid Corp. Form of Stock Option Agreement

INNOVID CORP. 2021 OMNIBUS INCENTIVE PLAN STOCK OPTION GRANT NOTICE Capitalized terms not specifically defined in this Stock Option Grant Notice (the “Grant Notice”) have the meanings given to them in the 2021 Omnibus Incentive Plan (as amended from time to time, the “Plan”) of Innovid Corp. (the “Company”). The Company has granted to the participant listed below (“Participant”) the stock option d

March 3, 2023 EX-21.1

List of Subsidiaries of the Company

Exhibit 21.1 Subsidiaries of Innovid Corp. as of December 31, 2022 Name Jurisdiction of Incorporation Innovid LLC Delaware TV Squared Inc Delaware TV Squared Limited United Kingdom TV Squared GmbH Germany Innovid Holdings LLC Delaware Innovid AU Pty Ltd Australia Innovid EU Limited United Kingdom Innovid Media Ltd. Israel Innovid Argentina SRL Argentina

February 24, 2023 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 24, 2023 Innovid Corp. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 24, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

February 24, 2023 EX-99.1

Innovid Reports Q4 and Fiscal Year 2022 Financial Results

Innovid Reports Q4 and Fiscal Year 2022 Financial Results •Reports Q4 revenue grew to $33.

February 9, 2023 EX-99.1

Innovid Names Ken Markus Chief Operating Officer Google veteran to lead cross-functional, company-wide operations building increased value for customers through best-in-class services

Innovid Names Ken Markus Chief Operating Officer Google veteran to lead cross-functional, company-wide operations building increased value for customers through best-in-class services New York, NY – February 9, 2023 – Innovid Corp.

February 9, 2023 8-K

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com

January 23, 2023 8-K

Regulation FD Disclosure

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 23, 2023 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Com

November 14, 2022 EX-31.02

Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).

Exhibit 31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Tanya Andreev-Kaspin, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w

November 14, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 5 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem

November 14, 2022 EX-32.02

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted p

November 14, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 6 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe

November 14, 2022 EX-31.01

Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)

Exhibit 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zvika Netter, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which suc

November 14, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 14, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

November 14, 2022 EX-32.01

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted p

November 14, 2022 EX-99.01

Innovid Reports Third Quarter 2022 Financial Results Increased revenue by 47% year-over-year to $34.5 million CTV accounted for 54% of the volume of all video impressions served TV measurement accounted for 23% of all revenue Generated net loss of $1

Exhibit 99.1 Innovid Reports Third Quarter 2022 Financial Results Increased revenue by 47% year-over-year to $34.5 million CTV accounted for 54% of the volume of all video impressions served TV measurement accounted for 23% of all revenue Generated net loss of $11.8 million and adjusted EBITDA* of $2.9 million, representing an 8% adjusted EBITDA margin* Innovid to host Investor Day on November 16,

November 14, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numbe

October 19, 2022 SC 13G/A

CTV / Innovid Corp / Vintage Fund 5 Ltd. - AMENDMENT NO. 1 TO SCHEDULE 13G Passive Investment

SC 13G/A 1 ea166824-13ga1vintage5innov.htm AMENDMENT NO. 1 TO SCHEDULE 13G SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* Innovid Corp. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title

August 10, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001

August 10, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 4 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem

August 10, 2022 EX-32.02

Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursua

August 10, 2022 EX-10.01

Amended and Restated Loan and Security Agreement, by and among Silicon Valley Bank, and each of the Borrowers set forth therein, dated August 4, 2022

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT THIS AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (this ?Agreement?) is dated as of the Effective Date between SILICON VALLEY BANK, a California corporation (?Bank?), and the borrowers listed on Schedule I hereto (?Borrower?).

August 10, 2022 424B3

INNOVID CORP.

424B3 1 innovid424b3resales-1.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 5 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784

August 10, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 10, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Comm

August 10, 2022 EX-31.02

Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a).

Exhibit 31.2 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Tanya Andreev-Kaspin, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w

August 10, 2022 EX-99.1

Innovid Reports Second Quarter 2022 Financial Results Delivered 45% year-over-year revenue growth to $33.1 million on an as-reported basis CTV accounted for 50% of the volume of all video impressions served TV measurement accounted for 22% of all rev

Exhibit 99.1 Innovid Reports Second Quarter 2022 Financial Results Delivered 45% year-over-year revenue growth to $33.1 million on an as-reported basis CTV accounted for 50% of the volume of all video impressions served TV measurement accounted for 22% of all revenue Launched InnovidXP ? the first cross-platform TV measurement solution powered by ad serving data and creative personalization NEW YO

August 10, 2022 EX-31.01

Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)

Exhibit 31.1 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zvika Netter, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Innovid Corp.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which suc

August 10, 2022 EX-32.01

Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report on Form 10-Q of Innovid Corp. (the “Company”) for the period ended June 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursua

July 8, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 4 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe

July 8, 2022 EX-99.1

Press Release dated July 8, 2022 by Innovid Corp.

Innovid Announces Changes to its Board of Directors NEW YORK, July. 8, 2022 - Innovid Corp. (NYSE:CTV) (the ?Company?), an independent advertising platform for delivery, personalization and measurement of converged TV across linear, connected TV (CTV) and digital, today announced changes in its board of directors (the ?Board?). Mr. Steven Cakebread has resigned for personal reasons and Mr. Brian H

July 8, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 3 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem

July 8, 2022 EX-99.1

Press Release dated July 8, 2022 by Innovid Corp.

EX-99.1 2 innovidannouncesachangeoni.htm EX-99.1 Innovid Announces Changes to its Board of Directors NEW YORK, July. 8, 2022 - Innovid Corp. (NYSE:CTV) (the “Company”), an independent advertising platform for delivery, personalization and measurement of converged TV across linear, connected TV (CTV) and digital, today announced changes in its board of directors (the “Board”). Mr. Steven Cakebread

July 8, 2022 EX-99.1

Innovid Announces Changes to its Board of Directors

Innovid Announces Changes to its Board of Directors NEW YORK, July. 8, 2022 - Innovid Corp. (NYSE:CTV) (the ?Company?), an independent advertising platform for delivery, personalization and measurement of converged TV across linear, connected TV (CTV) and digital, today announced changes in its board of directors (the ?Board?). Mr. Steven Cakebread has resigned for personal reasons and Mr. Brian H

July 8, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 innovid-8xkdirectorappoint.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 1, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction o

June 9, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 2 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem

June 9, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 3 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe

June 8, 2022 8-K

Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 8, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commiss

May 10, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 2 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe

May 10, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

May 10, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333- 264324 Prospectus Supplement No. 1 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supple

May 9, 2022 8-K/A

Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 3, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Comm

May 9, 2022 424B3

INNOVID CORP.

424B3 1 innovidcorp-424b3resale.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 1 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated April 12, 2022 (the “Prospectus”), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784)

May 9, 2022 EX-99.1

REPORT OF INDEPENDENT AUDITOR

EX-99.1 3 exhibit991-8xka.htm EX-99.1 Exhibit 99.1 REPORT OF INDEPENDENT AUDITOR Qualified Opinion We have audited the consolidated financial statements of TV Squared Limited (the Company), which comprise the Group Statements of Financial Position as of December 31, 2021, and the related Group Income Statement, Group Statement of Comprehensive Loss, Group Statement of Changes in Equity and Group S

May 9, 2022 EX-99.2

INNOVID CORP. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

Exhibit 99.2 INNOVID CORP. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION On February 6, 2022, Innovid Corp. (?Innovid?) entered into a Stock Purchase Agreement with TV Squared Limited, a private company limited by shares incorporated under the laws of Scotland (?TV Squared?). On February 28, 2022 (the ?Acquisition Date?), Innovid completed the acquisition of all outstanding equity i

May 9, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-264324 Prospectus Supplement No. 1 (To Prospectus dated May 3, 2022) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated May 3, 2022 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-264324). Capitalized terms used in this prospectus supplem

May 6, 2022 EX-99.1

Innovid Reports First Quarter 2022 Financial Results •Successfully completed the acquisition of TVSquared to establish an independent solution for global cross-platform TV measurement •Delivered 30% year-over-year revenue growth to $23.4 million excl

Exhibit 99.1 Innovid Reports First Quarter 2022 Financial Results ?Successfully completed the acquisition of TVSquared to establish an independent solution for global cross-platform TV measurement ?Delivered 30% year-over-year revenue growth to $23.4 million excluding TVSquared and 44% year-over-year revenue growth to $25.9 million on an as-reported basis ?Grew CTV revenue, excluding TVSquared, by

May 6, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 6, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Commissi

May 3, 2022 424B3

PROSPECTUS FOR 11,549,465 SHARES OF COMMON STOCK INNOVID CORP.

424B3 1 innovidtvsquared-424b3.htm 424B3 Filed Pursuant to Rule 425(b)(3) Registration No. 333-264324 PROSPECTUS FOR 11,549,465 SHARES OF COMMON STOCK OF INNOVID CORP. This prospectus relates to the resale from time to time of an aggregate of 11,549,465 shares of common stock, par value $0.0001 per share (the “common stock”), of Innovid Corp., a Delaware corporation (“Innovid”), issued in connecti

April 29, 2022 CORRESP

Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003

Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 April 29, 2022 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Innovid Corp Registration Statement on Form S-1 Filed April 15, 2022 File No. 333-264324 To whom it may concern: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended,

April 28, 2022 S-1/A

As filed with the Securities and Exchange Commission on April 15, 2022.

As filed with the Securities and Exchange Commission on April 15, 2022. Registration No. 333-264324 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other jurisdiction of incorporation or o

April 27, 2022 DEFA14A

DEFA14A

April 27, 2022 DEF 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amend

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.

April 15, 2022 S-1

As filed with the Securities and Exchange Commission on April 15, 2022.

As filed with the Securities and Exchange Commission on April 15, 2022. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 7374 87-3769599 (State or other jurisdiction of incorporation or organization) (Primary Sta

April 15, 2022 EX-FILING FEES

Filing Fees

Exhibit 107 CALCULATION OF REGISTRATION FEE FORM S-1 Innovid Corp. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit (1) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.0001 per share 457(c) 11,549,465 $5.96 $68,834,811.40 .0000927 $6,380.99 T

April 12, 2022 424B3

PROSPECTUS FOR 107,624,217 SHARES OF COMMON STOCK 7,060,000 WARRANTS TO PURCHASE SHARES OF COMMON STOCK 10,222,500 SHARES OF COMMON STOCK UNDERLYING WARRANTS INNOVID CORP.

Filed Pursuant to Rule 424(b)(3) ?Registration No 333-261784 PROSPECTUS FOR 107,624,217 SHARES OF COMMON STOCK 7,060,000 WARRANTS TO PURCHASE SHARES OF COMMON STOCK AND 10,222,500 SHARES OF COMMON STOCK UNDERLYING WARRANTS OF INNOVID CORP.

March 25, 2022 POS AM

As filed with the Securities and Exchange Commission on March 25, 2022.

As filed with the Securities and Exchange Commission on March 25, 2022. Registration No. 333- 261784 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware* 7374 87-3769599 (State or other jurisdiction of i

March 18, 2022 EX-3.1

Certificate of Incorporation of Innovid.

March 18, 2022 EX-4.4

Description of Securities

EX-4.4 3 a44descriptionofsecurities.htm EX-4.4 Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the capital stock of Innovid Corp. (“Innovid,” the “Company,” “we,” “us,” or “our”) and certain provisions of our amended and restated certificate of incorporation (the “Certifica

March 18, 2022 EX-3.1

Certificate of Incorporation of Innovid.

March 18, 2022 EX-21.1

List of Subsidiaries of the

Exhibit 21.1 Subsidiaries of Innovid Corp. as of December 31, 2021 Name Jurisdiction of Incorporation Innovid Corp. Delaware Innovid LLC Delaware Innovid Holdings LLC Delaware Innovid AU Pty Ltd Australia Innovid EU Limited United Kingdom Innovid Media Ltd. Israel Innovid Argentina SRL Argentina

March 18, 2022 424B3

INNOVID CORP.

Filed pursuant to Rule 424(b)(3) Registration Statement No. 333-261784 Prospectus Supplement No. 1 (To Prospectus dated December 30, 2021) INNOVID CORP. This prospectus supplement updates, amends and supplements the prospectus dated December 30, 2021 (the ?Prospectus?), which forms a part of our Registration Statement on Form S-1 (Registration No. 333-261784). Capitalized terms used in this prospe

March 18, 2022 EX-21.1

List of Subsidiaries of the

Exhibit 21.1 Subsidiaries of Innovid Corp. as of December 31, 2021 Name Jurisdiction of Incorporation Innovid Corp. Delaware Innovid LLC Delaware Innovid Holdings LLC Delaware Innovid AU Pty Ltd Australia Innovid EU Limited United Kingdom Innovid Media Ltd. Israel Innovid Argentina SRL Argentina

March 18, 2022 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-400

March 18, 2022 EX-4.4

DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

EX-4.4 3 a44descriptionofsecurities.htm EX-4.4 Exhibit 4.4 DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED The following is a description of the capital stock of Innovid Corp. (“Innovid,” the “Company,” “we,” “us,” or “our”) and certain provisions of our amended and restated certificate of incorporation (the “Certifica

March 3, 2022 8-K

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 28, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

March 3, 2022 EX-99.1

Innovid Completes TVSquared Acquisition, Establishing Global Independent Measurement Platform for Linear, CTV & Digital Acquisition Expected to Expand Global Market Opportunity and Contribute to Accelerated Revenue Growth in 2022

Innovid Completes TVSquared Acquisition, Establishing Global Independent Measurement Platform for Linear, CTV & Digital Acquisition Expected to Expand Global Market Opportunity and Contribute to Accelerated Revenue Growth in 2022 NEW YORK, NY, March 3, 2022 ? Innovid (NYSE: CTV), a leading independent connected TV (CTV) advertising delivery and measurement platform, has completed its previously announced acquisition of TVSquared, an independent global measurement and attribution platform for converged TV.

February 24, 2022 8-K

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 24, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation or organization) (Co

February 24, 2022 EX-99.1

Innovid Reports Q4 and Fiscal Year 2021 Financial Results •Increased revenue by 31% year-over-year, driven by growth in CTV plus increased adoption of personalization •Grew CTV revenue by 48% year-over-year •CTV accounted for 45% of total 2021 revenu

EX-99.1 2 a991innovidfy21financialsp.htm EX-99.1 Innovid Reports Q4 and Fiscal Year 2021 Financial Results •Increased revenue by 31% year-over-year, driven by growth in CTV plus increased adoption of personalization •Grew CTV revenue by 48% year-over-year •CTV accounted for 45% of total 2021 revenue, up from 40% in 2020 •Achieved adjusted EBITDA* of $5.4 million reflecting 110% growth year-over-ye

February 7, 2022 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 innovid-8xk.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 7, 2022 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorpora

February 7, 2022 EX-99.2

Innovid Announces Acquisition of Converged TV Measurement Leader, TVSquared Combination Expands Independent, Currency-Grade Measurement Platform Across TV, CTV & Digital

Innovid Announces Acquisition of Converged TV Measurement Leader, TVSquared Combination Expands Independent, Currency-Grade Measurement Platform Across TV, CTV & Digital ?Purchase price valued at approximately $160 million consists of $100 million in cash as well as additional stock consideration.

February 7, 2022 EX-2.1

Stock Purchase Agreement by and among Innovid Corp., TV Squared Limited, the stockholders of TV Squared Limited, Shareholder Representative Services LLC, dated February 6, 2022 (incorporated by reference to Exhibit 2.1 of Innovid’s Current Report on Form 8-K (File No. 001-40048), filed with the SEC on February 7, 2022).

STOCK PURCHASE AGREEMENT by and among TV SQUARED LIMITED THE SECURITY HOLDERS OF THE COMPANY SET FORTH ON ANNEX I HERETO SHAREHOLDER REPRESENTATIVE SERVICES LLC, AS SECURITY HOLDERS REPRESENTATIVE and INNOVID CORP.

February 7, 2022 EX-99.1

Innovid Provides Preliminary Q4 & Full Year 2021 Financial Results Update Management will Hold a Conference Call to Discuss Q4 and Full Year 2021 Financial Results on February 24 at 8:30 a.m. EST

Innovid Provides Preliminary Q4 & Full Year 2021 Financial Results Update Management will Hold a Conference Call to Discuss Q4 and Full Year 2021 Financial Results on February 24 at 8:30 a.

February 4, 2022 S-8

As filed with the United States Securities and Exchange Commission on February 4, 2022.

As filed with the United States Securities and Exchange Commission on February 4, 2022.

February 4, 2022 EX-99.3

Global Share Incentive Plan (2008).

INNOVID, Inc. Global Share Incentive Plan (2008) Fifth Amended and Restated on October 22, 2020 1. Name And Purpose 1.1 This plan as amended from time to time, originally established and adopted by the Board of Directors of the Company, Innovid, Inc. on September 25, 2008 and approved and adopted by the unanimous written consent of the stockholders effected October 4, 2008, and was amended and res

February 4, 2022 EX-FILING FEES

Filing Fees

CALCULATION OF REGISTRATION FEE FORM S-8 Innovid Corp. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Innovid Corp. 2021 Omnibus Incentive Plan Common Stock, par value $0.0001 per share 457(c) and 457(h) 40,000,000 (2)

December 30, 2021 SC 13G

CTV / Innovid Corp / Vintage Fund 5 Ltd. - SCHEDULE 13G Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title of Class of Securities) 457679 108 (CUSIP Number) November 30, 2021 (Date of

December 30, 2021 424B3

PROSPECTUS FOR 108,549,444 SHARES OF COMMON STOCK 7,060,000 WARRANTS TO PURCHASE SHARES OF COMMON STOCK 10,222,500 SHARES OF COMMON STOCK UNDERLYING WARRANTS INNOVID CORP.

Filed Pursuant to Rule 424(b)(3) ?Registration No 333-261784 PROSPECTUS FOR 108,549,444 SHARES OF COMMON STOCK 7,060,000 WARRANTS TO PURCHASE SHARES OF COMMON STOCK AND 10,222,500 SHARES OF COMMON STOCK UNDERLYING WARRANTS OF INNOVID CORP.

December 29, 2021 S-1/A

As filed with the Securities and Exchange Commission on December 29, 2021.

As filed with the Securities and Exchange Commission on December 29, 2021. Registration No. 333- 261784 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 To FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware* 7374 87-3769599 (State or other jurisdiction of incorporation

December 29, 2021 CORRESP

Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003

CORRESP 1 filename1.htm Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 December 29, 2021 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Office of Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Innovid Corp. Registration Statement on Form S-1 Filed December 20, 2021 File No. 333-261784 To whom it may concern: Pursuant to Rule 461(a) under the Secur

December 29, 2021 EX-99.1

INDEX TO FINANCIAL STATEMENT

Exhibit 99.1 INDEX TO FINANCIAL STATEMENT Audited Financial Statement for Innovid Corp. (F/K/A ION Acquisition Corp 2 Ltd.) : Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of February 16, 2021(as restated) F-3 Notes to Financial Statement (as restated) F-4 F-1 Kost Forer Gabbay & Kasierer 144 Menachem Begin Road, Building A Tel-Aviv 6492102, Israel Tel: +972-3-6

December 29, 2021 8-K/A

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 16, 2021 INNOVID CORP. (Exact name of registrant as specified in its charter) Delaware 333-252440 87-3769599 (State or other jurisdiction (Commission File Number) (I.R.S. E

December 21, 2021 EX-21.1

List of Subsidiaries of the Company

Exhibit 21.1 Subsidiaries of Innovid Corp. Name of Subsidiary Jurisdiction of Organization Innovid LLC Delaware

December 21, 2021 S-1

As filed with the Securities and Exchange Commission on December 20, 2021.

As filed with the Securities and Exchange Commission on December 20, 2021. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Innovid Corp. (Exact name of registrant as specified in its charter) Delaware* 7374 87-3769599 (State or other jurisdiction of incorporation or organization) (Primary

December 20, 2021 SC 13G

CTV / Innovid Corp / ION Holdings 2, LP - SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 INNOVID CORP. (Name of Issuer) Common Stock, Par Value $0.0001 per Share (Title of Class of Securities) 457679108 (CUSIP Number) December 31, 2021 (Date of event which requires filing of this statement) Check the appropriate box to designate the rule pursuant to which this

December 10, 2021 SC 13G

CTV / Innovid Corp / SEQUOIA CAPITAL ISRAEL IV, L.P. - SC 13G Passive Investment

SC 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed Pursuant to § 240.13d-2 Under the Securities Exchange Act of 1934 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 457

December 10, 2021 SC 13D

CTV / Innovid Corp / GENESIS PARTNERS III LP - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 457679 108 (CUSIP Number) c/o Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 (212) 966-7555 (Name, Address and Telephone Number of Person Authorized to Receive Notice

December 10, 2021 SC 13D

CTV / Innovid Corp / Netter Zvika - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Innovid Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 457679 108 (CUSIP Number) c/o Innovid Corp. 30 Irving Place, 12th Floor New York, NY 10003 (212) 966-7555 (Name, Address and Telephone Number of Person Authorized to Receive Notice

December 6, 2021 EX-10.7

Director Compensation program

Exhibit 10.7 Innovid Corp. Non-Employee Director Compensation Program Non-employee members of the board of directors (the ?Board?) of Innovid, Inc. (the ?Company?) shall receive cash and equity compensation as set forth in this Non-Employee Director Compensation Program (this ?Program?). The cash and equity compensation described in this Program shall be paid or be made, as applicable, automatical

December 6, 2021 EX-21.1

List of Subsidiaries of the Company.

Exhibit 21.1 Subsidiaries of Innovid Corp. Name of Subsidiary Jurisdiction of Organization Innovid LLC Delaware

December 6, 2021 EX-4.1

Specimen Common Stock Certificate of Innovid Corp. (incorporated by reference to Exhibit 4.1 of Innovid’s Current Report on Form 8-K (File No. 001-40048), filed with the SEC on December 6, 2021).

Exhibit 4.1 NUMBER SHARES C- SEE REVERSE FOR CERTAIN DEFINITIONS CUSIP INNOVID CORP. COMMON STOCK THIS CERTIFIES THAT is the owner of common stock, par value $0.0001 per share (each, a ?Common Stock?), of Innovid Corp., a Delaware corporation (the ?Company?), transferable on the books of the Company in person or by duly authorized attorney upon surrender of this certificate properly endorsed. This

December 6, 2021 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Change in Shell Company Status, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Completion of Acquisition or Disposition of Assets, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 30, 2021 INNOVID CORP. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-40048 (Commission File Number) 87-37

December 6, 2021 EX-99.2

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

Exhibit 99.2 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction: On June 24, 2021, ION Acquisition Corp 2 Ltd., a Cayman Islands exempted company (?ION?), entered into an Agreement and Plan of Merger (the ?Merger Agreement?) with Inspire Merger Sub 1, Inc., a Delaware corporation and a direct, wholly owned subsidiary of ION (?Merger Sub 1?). The following unaudited pro forma

December 6, 2021 EX-10.8

Form of Indemnification Agreement with Executive Officers and Directors of Innovid Corp. (incorporated by reference to Exhibit 10.8 of Innovid’s Current Report on Form 8-K (File No. 001-40048), filed with the SEC on December 6, 2021).

Exhibit 10.8 INDEMNIFICATION AND ADVANCEMENT AGREEMENT This Indemnification and Advancement Agreement (?Agreement?) is made as of , 2021 by and between Innovid Corp., a Delaware corporation (the ?Company?), and , [a member of the Board of Directors] [an officer] of the Company (?Indemnitee?). This Agreement supersedes and replaces any and all previous Agreements between the Company and Indemnitee

December 6, 2021 EX-10.2

Investor Rights Agreement,

Exhibit 10.2 Execution Version INVESTOR RIGHTS AGREEMENT THIS INVESTOR RIGHTS AGREEMENT (this ?Agreement?), dated as of November 30, 2021, is made and entered into by and among: (1)Innovid Corp., a Delaware corporation (the ?Company?), which was formerly named ION Acquisition Corp 2 Ltd. (?ION?); (2)certain equityholders of ION listed on Schedule A hereto ( the ?SPAC Holders?); and (3)certain form

December 6, 2021 EX-4.2

Specimen Warrant Certificate of Innovid Corp. (incorporated by reference to Exhibit 4.2 of Innovid’s Current Report on Form 8-K (File No. 001-40048), filed with the SEC on December 6, 2021).

Exhibit 4.2 [Form of Warrant Certificate] [FACE] Number [ ] Warrants THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE WARRANT AGREEMENT DESCRIBED BELOW INNOVID CORP. Incorporated Under the Laws of the State of Delaware CUSIP [ ] Warrant Certificate This certifies that [ ], or registered assigns, is the registered holder of [ ] warrants

December 6, 2021 EX-3.2

Bylaws of Innovid Corp. (incorporated by reference to Exhibit 3.2 to Innovid’s Current Report on Form 8-K (File No. 001-40048), filed with the SEC on December 6, 2021).

Exhibit 3.2 Amended and Restated Bylaws of Innovid Corp. (a Delaware corporation) TABLE OF CONTENTS Page Article I - Corporate Offices 1 1.1 Registered Office 1 1.2 Other Offices 1 Article II - Meetings of Stockholders 1 2.1 Place of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Business to be Brought Before a Meeting 1 2.5 Notice of Nominations for Election to the Board 5 2.

December 6, 2021 EX-3.1

Amended and Restated Certificate of Incorporation of ION Acquisition Corp II Ltd. (incorporated by reference to Exhibit 3.1 to Innovid’s Current Report on Form 8-K (File No. 001-40048), filed with the SEC on December 6, 2021).

Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ION ACQUISITION CORP 2 ION Acquisition Corp 2 (the ?Corporation?), a corporation organized and existing under the General Corporation Law of the State of Delaware (the ?DGCL?), does hereby certify as follows: 1.The name of the Corporation is ION Acquisition Corp 2. The Corporation was incorporated under the name ION Acquisition Corp

December 6, 2021 EX-99.1

INNOVID, INC. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except stock and per stock data)

Exhibit 99.1 INNOVID, INC. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except stock and per stock data) September 30, 2021 December 31, 2020 (Unaudited) ASSETS CURRENT ASSETS: Cash and cash equivalents $ 14,472 $ 15,645 Trade receivables, net (allowance for doubtful accounts of $83 and $121 at September 30, 2021 and December 31, 2020, respectively) 34,223 34,804 Prepa

December 6, 2021 EX-99.3

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF INNOVID

Exhibit 99.3 MANAGEMENT?S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF INNOVID The following discussion and analysis should be read in conjunction with the unaudited condensed financial statements and audited financials statements and related notes of Innovid either included in the final prospectus and definitive proxy statement/prospectus (the ?Proxy?) relating to t

December 1, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 30, 2021 INNOVID CORP. (Exact name of registrant as specified in its charter) Delaware 001-40048 87-3769599 (State or other jurisdiction of incorporation) (Commission File Nu

December 1, 2021 EX-99.25

EX-99.25

NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on December 13, 2021, pursuant to the provisions of Rule 12d2-2 (a).

December 1, 2021 EX-99.1

Innovid Begins Trading on New York Stock Exchange Under Symbol “CTV”

Exhibit 99.1 Innovid Begins Trading on New York Stock Exchange Under Symbol ?CTV? ?Global leader in Connected TV ad delivery and measurement begins trading today as Innovid, under the new ticker symbol ?CTV? ?The transaction generated approximately $251 million of proceeds including financing anchored by top-tier institutional investors ?Global brands and agencies tap Innovid as the independent le

November 30, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 30, 2021 ION ACQUISITION CORP 2 LTD. (Exact name of registrant as specified in its charter) Delaware 001-40048 N/A (State or other jurisdiction of incorporation) (Commission

November 30, 2021 EX-99.1

IACB Shareholders Vote to Approve the Proposed Business Combination with Innovid

Exhibit 99.1 IACB Shareholders Vote to Approve the Proposed Business Combination with Innovid NEW YORK, NY ? November 29, 2021 - ION Acquisition Corp 2, Ltd. (?ION?) (NYSE:IACB), a special purpose acquisition company, announced today that its shareholders voted to approve the previously announced business combination with Innovid Inc. (?Innovid? or the ?Company?), a leading independent connected T

November 26, 2021 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 20

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 00

November 26, 2021 8-K

Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 26, 2021 (November 25, 2021) ION ACQUISITION CORP 2 LTD. (Exact name of registrant as specified in its charter) Cayman Islands 001-40048 N/A (State or other jurisdiction of i

November 17, 2021 425

ION Announces Innovid’s Financial Results for the Nine Months Ended September 30, 2021

Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. (File No. 001-40048) ION Announces Innovid?s Financial Results for the Nine Months Ended September 30, 2021 ?Revenue of $64.3 million is up 41% over last year, driven by 65% growth

November 17, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 17, 2021 ION Acquisition Corp 2 Ltd. (Exact name of registrant as specified in its charter) Cayman Islands 001-40048 N/A (State or other jurisdiction of incorporation) (Commi

November 17, 2021 EX-99.1

ION Announces Innovid’s Financial Results for the Nine Months Ended September 30, 2021

Exhibit 99.1 ION Announces Innovid?s Financial Results for the Nine Months Ended September 30, 2021 ? Revenue of $64.3 million is up 41% over last year, driven by 65% growth in revenue from CTV ? Adjusted EBITDA of $3.7 million surges 201% vs. one year ago, representing a 6% adjusted EBITDA margin ? Expected to start trading as Innovid, under the new ticker symbol ?CTV? on December 1, 2021, after

November 15, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40048 ION ACQUISIT

November 10, 2021 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 ION Acquisition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 ION Acquisition Corp 2 Ltd. (Exact name of registrant as specified in its charter) Cayman Islands 001-40048 N/A (State or other jurisdiction of incorporation) (Commi

November 10, 2021 EX-99.1

ION Acquisition Corp 2 Ltd. and Innovid, Inc. Announce Effectiveness of Registration Statement and Special Meeting Date for Proposed Business Combination

Exhibit 99.1 ION Acquisition Corp 2 Ltd. and Innovid, Inc. Announce Effectiveness of Registration Statement and Special Meeting Date for Proposed Business Combination ? Special meeting of ION Acquisition Corp 2 Ltd.?s stockholders to approve the proposed business combination with Innovid, Inc. to be held on November 29, 2021 New York, NY ? November 10, 2021 ? ION Acquisition Corp 2 Ltd. (NYSE: IAC

November 10, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 10, 2021 ION Acquisition Corp 2 Ltd. (Exact name of registrant as specified in its charter) Cayman Islands 001-40048 N/A (State or other jurisdiction of incorporation) (Commi

November 10, 2021 EX-99.1

ION Acquisition Corp 2 Ltd. and Innovid, Inc. Announce Effectiveness of Registration Statement and Special Meeting Date for Proposed Business Combination

EX-99.1 2 ea150363ex99-1ionacq2.htm PRESS RELEASE, DATED AS OF NOVEMBER 10, 2021 Exhibit 99.1 ION Acquisition Corp 2 Ltd. and Innovid, Inc. Announce Effectiveness of Registration Statement and Special Meeting Date for Proposed Business Combination ● Special meeting of ION Acquisition Corp 2 Ltd.’s stockholders to approve the proposed business combination with Innovid, Inc. to be held on November 2

November 10, 2021 424B3

PROXY STATEMENT FOR EXTRAORDINARY GENERAL MEETING OF ION ACQUISITION CORP 2 LTD. (A CAYMAN ISLANDS EXEMPTED COMPANY) PROSPECTUS FOR 124,880,615 SHARES OF COMMON STOCK AND 10,222,500 WARRANTS TO PURCHASE SHARES OF COMMON STOCK OF ION ACQUISITION CORP

Filed Pursuant to Rule 424(b)(3) Registration No. 333-258472 PROXY STATEMENT FOR EXTRAORDINARY GENERAL MEETING OF ION ACQUISITION CORP 2 LTD. (A CAYMAN ISLANDS EXEMPTED COMPANY) PROSPECTUS FOR 124,880,615 SHARES OF COMMON STOCK AND 10,222,500 WARRANTS TO PURCHASE SHARES OF COMMON STOCK OF ION ACQUISITION CORP 2 LTD. (TO BE RENAMED ?INNOVID CORP.? FOLLOWING DOMESTICATION IN THE STATE OF DELAWARE AN

November 8, 2021 CORRESP

ION Acquisition Corp. 2 Ltd. 89 Medinat Hayehudim Street Herzliya 5676672, Israel

CORRESP 1 filename1.htm ION Acquisition Corp. 2 Ltd. 89 Medinat Hayehudim Street Herzliya 5676672, Israel November 8, 2021 VIA EDGAR Division of Corporation Finance Office of Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: ION Acquisition Corp. 2, Ltd. Amendment No. 3 to Registration Statement on Form S-4 Filed November 5, 2021 File No. 333-258472 Ladies an

November 5, 2021 EX-99.6

Consent of Steven Cakebread to be Named as a Director.

Exhibit 99.6 Innovid, Inc. (the Company) Consent to act as a director of the Company To: The Company I consent to act as a director of the Company subject to, and with the benefit of the provisions of, the Company's certificate of incorporation with effect from the date of this letter. I certify that I have attained the age of 18 years. I am not disqualified by the bylaws and certificate of incorp

November 5, 2021 S-4/A

As Previously Reported Adjustment As Restated Balance Sheet as of February 16, 2021 Warrants liability $ — $ 30,065,074 $ 30,065,074 Total liabilities 9,361,700 30,065,074 39,426,774 Class A ordinary shares subject to possible redemption (A) 240,641,

As filed with the United States Securities and Exchange Commission on November 5, 2021.

November 5, 2021 EX-99.5

Consent of Jonathan Saacks to be Named as a Director.

Exhibit 99.5 Innovid, Inc. (the Company) Consent to act as a director of the Company To: The Company I consent to act as a director of the Company subject to, and with the benefit of the provisions of, the Company's certificate of incorporation with effect from the date of this letter. I certify that I have attained the age of 18 years. I am not disqualified by the bylaws and certificate of incorp

November 5, 2021 EX-99.3

Consent of Rachel Lam to be Named as a Director.

Exhibit 99.3 Innovid, Inc. (the Company) Consent to act as a director of the Company To: The Company I consent to act as a director of the Company subject to, and with the benefit of the provisions of, the Company's certificate of incorporation with effect from the date of this letter. I certify that I have attained the age of 18 years. I am not disqualified by the bylaws and certificate of incorp

November 5, 2021 EX-99.4

Consent of Michael DiPiano to be Named as a Director.

Exhibit 99.4 Innovid, Inc. (the Company) Consent to act as a director of the Company To: The Company I consent to act as a director of the Company subject to, and with the benefit of the provisions of, the Company's certificate of incorporation with effect from the date of this letter. I certify that I have attained the age of 18 years. I am not disqualified by the bylaws and certificate of incorp

November 5, 2021 CORRESP

* * *

CORRESP 1 filename1.htm November 5, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D.C. 20549 Attn: Rebekah Lindsey, Senior Staff Accountant Christine Dietz, Accounting Branch Chief Mitchell Austin, Staff Attorney Jan Woo, Legal Branch Chief Re: ION Acquisition Corp 2 Ltd. Amendment No. 2 to Registra

October 25, 2021 EX-99.1

Form of Preliminary Proxy Card.

Exhibit 99.1 slide1 ION Acquisition Corp 2 LTD. (?ION?) THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON [ ], Capitalized terms used and not otherwise defined herein shall have the respective meanings ascribed to them in the proxy statement/prospectus, dated [ ], to which this Proxy is attached, or in the Merger Agreement (as defined below). The

October 25, 2021 S-4/A

As Previously Reported Adjustment As Restated Balance Sheet as of February 16, 2021 Warrants liability $ — $ 30,065,074 $ 30,065,074 Total liabilities 9,361,700 30,065,074 39,426,774 Class A ordinary shares subject to possible redemption (A) 240,641,

As filed with the United States Securities and Exchange Commission on October 25, 2021.

October 25, 2021 CORRESP

* * *

October 25, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D.

October 25, 2021 425

DAY Th e pre s e n t a ti on will begin shortly F A ile d N by I O A N LYST Acquisition Corp 2 Ltd. pursuant to Rule 425 under the S P e c R u E ri t S ie s E A N c t T o A f 1 T 9 3 I O 3 N and deemed filed p O ur s C u T an t | t 2 o R 0 u 2 l e 1

425 1 ea149288-425ionacquisit2.htm FORM 425 Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No. 001-40048 This filing relates to the proposed merger involving ION Acquisition Corp. 2 Ltd. (“ION”) with Innovid, Inc

October 25, 2021 425

Filed by ION Acquisition Corp 2 Ltd. pursuant to

425 1 ea149289-425ionacq2.htm FORM 425 Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 This filing relates to the proposed merger involving ION Acquisition Corp. 2 Ltd. (“ION”) with Innovid, Inc. (“

October 20, 2021 EX-99.1

Innovid Announces PIPE Investment Expansion To $200MM Global leader in connected TV ad delivery and measurement continues to receive strong investor support

EX-99.1 2 ea148996ex99-1ionacq2.htm PRESS RELEASE, DATED OCTOBER 20, 2021 Exhibit 99.1 Innovid Announces PIPE Investment Expansion To $200MM Global leader in connected TV ad delivery and measurement continues to receive strong investor support New York - October 20, 2021 - Innovid, a leading independent connected TV (CTV) advertising delivery and measurement platform, and ION Acquisition Corp. 2 L

October 20, 2021 425

Filed by ION Acquisition Corp 2 Ltd. pursuant to

Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 The SPAC frenzy has cooled. But adtech company Innovid just got a $50 million vote of confidence in its deal to go public. Ryan Joe Just now innovid ?

October 20, 2021 EX-99.1

Innovid Announces PIPE Investment Expansion To $200MM Global leader in connected TV ad delivery and measurement continues to receive strong investor support

Exhibit 99.1 Innovid Announces PIPE Investment Expansion To $200MM Global leader in connected TV ad delivery and measurement continues to receive strong investor support New York - October 20, 2021 - Innovid, a leading independent connected TV (CTV) advertising delivery and measurement platform, and ION Acquisition Corp. 2 Ltd. (?ION?) (NYSE:IACB), a special purpose acquisition company, today anno

October 20, 2021 425

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 20, 2021 (October 18, 202

425 1 ea148996-8kionacq2.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 20, 2021 (October 18, 2021) ION ACQUISITION CORP 2 LTD. (Exact name of registrant as specified in its charter) Cayman Islands 333-2

October 20, 2021 8-K

Regulation FD Disclosure, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 20, 2021 (October 18, 2021) ION ACQUISITION CORP 2 LTD. (Exact name of registrant as specified in its charter) Cayman Islands 333-252440 N/A (State or other jurisdiction of in

October 19, 2021 425

Filed by ION Acquisition Corp 2 Ltd. pursuant to

Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 A transcript of an interview that took place at Citi 2021 Global Technology Virtual Conference with Zvika Netter, CEO and Co-founder of Innovid, Inc.,

October 19, 2021 425

Filed by ION Acquisition Corp 2 Ltd. pursuant to

Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 A transcript from a presentation given at the Jefferies Israel Innovation Summit by Zvika Netter, CEO and Co-founder of Innovid, Inc., on September 30

October 19, 2021 425

Filed by ION Acquisition Corp 2 Ltd. pursuant to

Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 A transcript of an interview that took place at the Piper Sandler Global Technology Conference TechTok with Zvika Netter, CEO and Co-founder of Innovi

October 6, 2021 S-4/A

As Previously Reported Adjustment As Restated Balance Sheet as of February 16, 2021 Warrants liability $ — $ 30,065,074 $ 30,065,074 Total liabilities 9,361,700 30,065,074 39,426,774 Class A ordinary shares subject to possible redemption (A) 240,641,

As filed with the United States Securities and Exchange Commission on October 5, 2021.

October 5, 2021 CORRESP

* * *

October 5, 2021 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Technology 100 F Street, NE Washington, D.

September 2, 2021 425

Filed by ION Acquisition Corp 2 Ltd. pursuant to

Filed by ION Acquisition Corp 2 Ltd. pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 under the Securities Exchange Act of 1934 Subject Company: ION Acquisition Corp 2 Ltd. Commission File No.: 001-40048 The following is an excerpt from a presentation given by Innovid, Inc. Chief Executive Officer Zvika Netter to potential investors on August 15, 2021.

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista